Glancy prongay & murray llp reminds investors of looming deadline in the class action lawsuit against ampio pharmaceuticals, inc. (ampe)

Los angeles--(business wire)--glancy prongay & murray llp (“gpm”) reminds investors of the upcoming october 17, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ampio pharmaceuticals, inc. (“ampio” or the “company”) (nyse american: ampe) common stock between december 29, 2020 and august 3, 2022, inclusive (the “class period”). if you suffered a loss on your ampio investments or would like to inquire about pote
AMPE Ratings Summary
AMPE Quant Ranking